Filing Details
- Accession Number:
- 0001209191-17-021733
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-03-20 16:36:22
- Reporting Period:
- 2017-03-16
- Filing Date:
- 2017-03-20
- Accepted Time:
- 2017-03-20 16:36:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1088856 | Corcept Therapeutics Inc | CORT | Pharmaceutical Preparations (2834) | 770487658 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1253886 | G Patrick Enright | C/O Longitude Capital Partners, Llc 800 El Camino Real, Suite 220 Menlo Park CA 94025 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-03-16 | 264,650 | $9.94 | 5,721,372 | No | 4 | S | Indirect | By LVP |
| Common Stock | Disposition | 2017-03-16 | 5,305 | $9.94 | 114,675 | No | 4 | S | Indirect | By LCA |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By LVP |
| No | 4 | S | Indirect | By LCA |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 272,281 | Direct |
Footnotes
- Reflects sales of common stock of the Issuer executed in multiple transactions at prices ranging from $9.855 to $10.255 per share. The price reported reflects the weighted-average price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects the pro rata distribution by Longitude Venture Partners, L.P. ("LVP") and Longitude Capital Partners, L.P. ("LCA") on March 16, 2017 of shares of common stock of the Issuer to their respective partners for no consideration, and the subsequent pro rata distribution by Longitude Capital Partners, LLC ("LCP"), the sole general partner of LVP and LCA, on March 16, 2017 of shares of common stock of the Issuer to its members for no consideration. As a result of these distributions, the Reporting Person received and became the direct holder of 68,071 shares of common stock of the Issuer.
- Reflects shares of common stock of the Issuer held of record by LVP and LCA. Mr. Enright is a managing member of LCP, the sole general partner of LVP and LCA. Mr. Enright disclaims beneficial ownership of the securities of the Issuer held of record by LVP and LCA, except to the extent of his pecuniary interest therein.
Billionaire Hedge Funds
